Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00828074 | Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer | completed | Phase 1 / Phase 2 | 46 | City of Hope Medical CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00003761 | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT02583568 |
| Fluorescence Guided Surgery in Breast Cancer(MARGIN) |
| completed |
| Phase 1 / Phase 2 |
| 26 |
| University Medical Center GroningenOTHER |
| 1 |
| Feb 13, 2017 |
| clinicaltrials |
| NCT00826085 | Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall(DIGNITY) | completed | Phase 1 / Phase 2 | 17 | ImunonINDUSTRY | 1 | Jan 30, 2017 | clinicaltrials |
| NCT00755885 | Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 77 | Cancer Research UKOTHER | 1 | Jan 26, 2017 | clinicaltrials |
| NCT01339442 | BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer | completed | Phase 1 | 31 | Washington University School of MedicineOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT00005886 | Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer | completed | Phase 1 | — | University of Kansas Medical CenterOTHER | 1 | Jan 13, 2017 | clinicaltrials |
| NCT00849459 | Gene Therapy in Treating Women With Metastatic Breast Cancer | completed | Phase 1 | 3 | Max SungOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT00068263 | 3-Dimensional Conformal Radiation Therapy In Treating Women With Stage I or Stage II Breast Cancer Previously Treated With Lumpectomy and Axillary Node Dissection | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jan 4, 2017 | clinicaltrials |
| NCT00070057 | Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer | completed | Phase 1 | 75 | National Cancer Institute (NCI)NIH | 1 | Dec 29, 2016 | clinicaltrials |
| NCT00637481 | A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Dec 29, 2016 | clinicaltrials |
| NCT00800436 | A Dose-Finding Study of Subcutaneous Herceptin (Trastuzumab) in Healthy Male Volunteers and Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Females | completed | Phase 1 | 66 | Hoffmann-La RocheINDUSTRY | 2 | Dec 16, 2016 | clinicaltrials |
| NCT00892567 | Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer(Breast 37) | completed | Phase 1 | 9 | Craig L Slingluff, JrOTHER | 1 | Dec 16, 2016 | clinicaltrials |
| NCT01372644 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial | completed | Phase 1 | 15 | NYU Langone HealthOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT00882674 | A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer | completed | Phase 1 | 8 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01172223 | Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer(LAPADO) | completed | Phase 1 / Phase 2 | 81 | Prof Dirk EllingOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01254526 | Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 1 | 52 | Genentech, Inc.INDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT01493336 | A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours | completed | Phase 1 | 37 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT01513083 | A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function | completed | Phase 1 | 28 | Hoffmann-La RocheINDUSTRY | 5 | Nov 2, 2016 | clinicaltrials |
| NCT02621957 | Effect of GDC-0810 on the Pharmacokinetics of Pravastatin in Healthy Female Subjects of Non-Childbearing Potential | completed | Phase 1 | 15 | Genentech, Inc.INDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Beth Israel Deaconess Medical CenterOTHER | 1 | Oct 20, 2016 | clinicaltrials |
| NCT01432886 | A Study of Eribulin Mesylate With Trastuzumab for Advanced or Recurrent Human Epidermal Growth Factor Receptor 2-Positive (HER2+) Breast Cancer | completed | Phase 1 | 12 | Eisai Co., Ltd.INDUSTRY | 1 | Oct 7, 2016 | clinicaltrials |
| NCT01522820 | Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors | completed | Phase 1 | 18 | Roswell Park Cancer InstituteOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT01384253 | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy | completed | Phase 1 | 18 | Orano Med LLCINDUSTRY | 1 | Sep 30, 2016 | clinicaltrials |
| NCT00573495 | Multipeptide Vaccine for Advanced Breast Cancer | completed | Phase 1 | 11 | University of PennsylvaniaOTHER | 1 | Sep 29, 2016 | clinicaltrials |
| NCT02033551 | A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors | completed | Phase 1 | 47 | AbbVieINDUSTRY | 3 | Sep 27, 2016 | clinicaltrials |
| NCT00691379 | Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT01640665 | Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors | completed | Phase 1 | 24 | Yale UniversityOTHER | 1 | Sep 16, 2016 | clinicaltrials |
| NCT01451632 | A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers | completed | Phase 1 | 48 | Merrimack PharmaceuticalsINDUSTRY | 1 | Sep 8, 2016 | clinicaltrials |
| NCT00887575 | Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer | completed | Phase 1 / Phase 2 | 54 | SCRI Development Innovations, LLCOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT00033345 | Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer | completed | Phase 1 | 17 | University of Kansas Medical CenterOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT01045421 | Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies | completed | Phase 1 / Phase 2 | 273 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 15, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01248494 | PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer | completed | Phase 1 | 72 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 25, 2016 | clinicaltrials |
| NCT02418481 | Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00450892 | Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | completed | Phase 1 / Phase 2 | 129 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 7, 2016 | clinicaltrials |
| NCT00951665 | A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2016 | clinicaltrials |
| NCT01155258 | Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 19 | University of Southern CaliforniaOTHER | 1 | Jun 13, 2016 | clinicaltrials |
| NCT01042925 | Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen | completed | Phase 1 / Phase 2 | 42 | SanofiINDUSTRY | 2 | Jun 3, 2016 | clinicaltrials |
| NCT01082068 | Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer | completed | Phase 1 / Phase 2 | 72 | SanofiINDUSTRY | 3 | Jun 3, 2016 | clinicaltrials |
| NCT00327743 | Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 34 | SanofiINDUSTRY | 2 | May 18, 2016 | clinicaltrials |
| NCT00574366 | Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 14 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | May 10, 2016 | clinicaltrials |
| NCT01288261 | Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer | completed | Phase 1 | 14 | University of ArizonaOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT01459172 | Human Breast Tissue Bioavailability of Topically Applied Limonene | completed | Phase 1 | 103 | University of ArizonaOTHER | 1 | Apr 21, 2016 | clinicaltrials |
| NCT01276496 | Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 15, 2016 | clinicaltrials |
| NCT00012129 | Chemotherapy in Treating Patients With Breast Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 11, 2016 | clinicaltrials |
| NCT00182767 | Ixabepilone and Liposomal Doxorubicin in Advanced Ovarian Cancer | completed | Phase 1 / Phase 2 | 45 | National Cancer Institute (NCI)NIH | 1 | Mar 10, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2017source: clinicaltrials